Smart Money Alert

Ind-Swift Laboratories Limited

IncreasedSAST

INDSWFTLABPharmaceuticalsMarket Cap₹3K Cr

Stake

43.06% → 47.18%

Deal value

₹264.77 Cr

70.00 L

Trade date

17 Sept 2026

Since alert−11.4%₹405.55 → ₹359.25

Nifty 50−0.8%

Essix Biosciences Limited

Promoter

The move

Essix Biosciences Limited and its persons acting in concert increased their stake in Ind-Swift Laboratories Limited from 43.06% to 47.18%, acquiring 70,00,000 fully convertible warrants on a preferential basis.

About Ind-Swift Laboratories Limited

Visit stock

A pharmaceutical manufacturer engaged in the production of bulk drugs and formulations, Ind-Swift Laboratories operates across India's medicinal compounds sector. Established in 1995, the company focuses on developing and supplying active pharmaceutical ingredients and finished dosage forms to both domestic and international markets. Its integrated operations span research, manufacturing, quality control, and distribution within the broader pharmaceutical value chain.

Get the next move the moment it happens.

Follow the investors and Ind-Swift Laboratories Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Ind-Swift Laboratories Limited shareholders All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Ind-Swift Laboratories Limited

Nova Global

Direction, size, price and stake change for this move, with what it means for the company.

15 Oct 2026. Sign in to see this move

Nova GlobalNew position

Nova Global entered Ind-Swift Laboratories with 25,72,991 shares, a 2.96% stake, valued at approximately ₹59.63 Cr.